News 2016-05-20
Porton Wins Major J&J Global Supplier Awards.
We are pleased to announce that Johnson & Johnson (J&J) has honored Porton Fine Chemicals (Porton) with a Bronze Award, the highest honor accorded by J&J to its suppliers in the pharmaceutical chemical category at its Annual Global Supplier Event held on May 17, 2016 in Belgium. The award recognizes Porton for our innovation, reliability and overall performance. Porton was also given the CREDO Award in recognition of our compassionate care and human welfare of employees and communities. As a Strategic Partner and Key Supplier to J&J and several other global pharmaceutical companies, Porton is proud to help our Customers efficiently deliver improved health outcomes for their patients through innovative, high-quality and reliable drug development, manufacturing and supply chain solutions.
Others
More
News 2025-03-21
Porton's Near-Term Target Validated by the SBTi
March 20, 2025, Chongqing—Porton Pharma Solutions Ltd. (Porton) announced today that its near-term greenhouse gas emissions reductions targets have been formally validated by the Science Based Targets initiative (SBTi). This milestone not only signifies its strategic breakthrough in climate governance, but also demonstrates that its decarbonization roadmap is aligned with the 1.5°C climate mitigation pathway.
News 2025-03-19
Porton Advanced Announces Collaboration with Eureka Therapeutics to Accelerate T Cell Therapy Development
Cranbury, New Jersey, March 19, 2025 — Porton Advanced, a leading contract development and manufacturing organization (CDMO) specializing in advanced therapy medicinal products (ATMPs), is pleased to announce its partnership with Eureka Therapeutics, Inc., a clinical-stage biotechnology company dedicated to developing novel T‑cell therapies for both solid tumors and hematologic malignancies.
